![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Amersin Subsidiary Secures New Ribavirin Contract
Amersin Subsidiary Secures New Ribavirin Contract
Hubei Tongji Benda Ebei Pharmaceutical Co., a subsidiary
of Amersin Life Sciences, has entered into a sales contract with Zhangjiang
Pharmacy Co. to supply 1.5 million doses of Ribavirin in injection form. Zhangjiang
Pharmacy is a pharmaceutical distribution company specializing in South East
Asia markets, including Thailand, Vietnam and Burma. Many of its customers,
especially those from Vietnam and Thailand, are building inventories of antiviral
products following recently confirmed human cases of bird flu (H5N1).
Big
News Network
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
11Jul
-
18Jul
-
21Oct